(Q40102582)

17 September 2017

Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis (English)

1 reference

17 September 2017

0 references

1 reference

1

1 reference

17 September 2017

2

1 reference

17 September 2017

4

1 reference

17 September 2017

Zimmermann D

3

1 reference

17 September 2017

Heinzel T

series ordinal

5

1 reference

17 September 2017

language of work or name

English

0 references

publication date

23 July 2007

1 reference

17 September 2017

1 reference

17 September 2017

27

1 reference

17 September 2017

6

1 reference

17 September 2017

732-740

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210677

17 September 2017

0 references

cites work

Are p27 and p21 cytoplasmic oncoproteins?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Histone deacetylase inhibitors and malignant melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Inducible p27(Kip1) expression inhibits proliferation of K562 cells and protects against apoptosis induction by proteasome inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

DNA repair: relationship to drug and radiation resistance, metastasis and growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Acetylation: a regulatory modification to rival phosphorylation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Acetylation of Stat1 modulates NF-kappaB activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Histone deacetylase as a therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Drug resistance in melanoma: new perspectives.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Differentiation of human malignant melanoma cells that escape apoptosis after treatment with 9-nitrocamptothecin in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Differential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Use of hydroxyurea to alter drug resistance of human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210677

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210677

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference